810 related articles for article (PubMed ID: 26669617)
1. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
[TBL] [Abstract][Full Text] [Related]
2. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
[TBL] [Abstract][Full Text] [Related]
3. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
[TBL] [Abstract][Full Text] [Related]
5. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
6. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
[TBL] [Abstract][Full Text] [Related]
8. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.
Ikeguchi M; Oi K; Hirooka Y; Kaibara N
Eur J Surg Oncol; 2004 Feb; 30(1):53-7. PubMed ID: 14736523
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
[TBL] [Abstract][Full Text] [Related]
10. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
11. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
[TBL] [Abstract][Full Text] [Related]
12. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
13. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
[TBL] [Abstract][Full Text] [Related]
15. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
Chew V; Tow C; Teo M; Wong HL; Chan J; Gehring A; Loh M; Bolze A; Quek R; Lee VK; Lee KH; Abastado JP; Toh HC; Nardin A
J Hepatol; 2010 Mar; 52(3):370-9. PubMed ID: 19720422
[TBL] [Abstract][Full Text] [Related]
17. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
18. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
[TBL] [Abstract][Full Text] [Related]
19. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
Chew V; Chen J; Lee D; Loh E; Lee J; Lim KH; Weber A; Slankamenac K; Poon RT; Yang H; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
Gut; 2012 Mar; 61(3):427-38. PubMed ID: 21930732
[TBL] [Abstract][Full Text] [Related]
20. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
